Stereotactic Body Radiation Therapy (5 days) + Surgical Resection + PEMBROLIZUMAB for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Jun 2021: Trial registered, NCT04938609
  2. 11 Jan 2022: Trial started, NCT04938609

The trials

NCT04938609: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

State
Under way
Phase
Phase 2
People
28 taking part
Started
11 Jan 2022
Primary completion
11 Jan 2027
Arms
Pembrolizumab + SBRT + Surgery
Results
None posted
  1. 24 Jun 2021: Trial registered
  2. 11 Jan 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.